Soleus Capital Management’s VistaGen Therapeutics VTGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-27,500
Closed -$726K 90
2022
Q2
$726K Buy
+27,500
New +$726K 0.11% 70